acut
respiratori
infect
ari
major
factor
respons
outpati
visit
hospit
infant
young
children
also
one
lead
caus
child
adult
morbid
mortal
worldwid
respiratori
virus
predomin
caus
ari
acut
respiratori
infect
etiolog
complex
often
remain
unknown
etiolog
determin
frequent
done
patient
respiratori
symptom
either
clinic
laboratori
influenzalik
ill
ili
subset
ari
attribut
wide
rang
respiratori
virus
includ
influenza
viru
ifv
respiratori
syncyti
viru
rsv
adenoviru
adv
human
coronavirus
parainfluenza
viru
improv
techniqu
molecular
biolog
result
highthrough
detect
sever
respiratori
virus
includ
novel
pathogen
human
metapneumoviru
hmpv
human
bocaviru
hbov
sever
acut
respiratori
syndrom
sar
coronaviru
human
coronaviru
coronaviru
rhinoviru
hrv
gener
consid
caus
mild
upper
respiratori
ill
patient
infect
divers
viral
pathogen
develop
wide
overlap
symptom
make
clinic
diagnosi
unreli
sever
limit
etioepidemiolog
investig
inform
contribut
influenza
virus
global
burden
diseas
due
acut
respiratori
ill
incomplet
clinic
symptom
viral
respiratori
infect
similar
distinguish
etiolog
agent
better
identif
broad
spectrum
respiratori
virus
ili
essenti
impel
public
health
offici
formul
effect
prevent
control
strategi
includ
monitor
influenza
vaccin
efficaci
commun
etiolog
agent
associ
ili
develop
countri
well
character
less
known
concern
epidemiolog
etiolog
ili
caus
agent
influenza
virus
small
number
group
report
preval
clinic
present
viral
respiratori
infect
china
far
molecular
epidemiolog
ili
conduct
huizhou
order
fill
gap
better
understand
etiolog
pattern
huizhou
clinic
characterist
epidemiolog
pattern
viral
pathogen
involv
ili
investig
local
popul
admit
huizhou
municip
central
hospit
ili
juli
juli
method
use
studi
repres
signific
improv
convent
method
detect
broad
spectrum
respiratori
virus
aspect
studi
approv
medic
ethic
review
board
center
diseas
control
prevent
huizhou
well
ethic
committe
huizhou
municip
central
hospit
written
inform
consent
obtain
parent
legal
guardian
children
enrol
studi
total
nasal
throat
swab
sampl
obtain
male
femal
ili
patient
admit
huizhou
municip
central
hospit
juli
juli
collect
individu
fever
bodi
temperatur
cough
least
two
follow
symptom
sore
throat
rhinorrhea
headach
muscular
pain
maximum
durat
day
epidemiolog
clinic
inform
includ
case
histori
symptom
physic
sign
examin
includ
standard
questionnair
sampl
collect
absenc
respiratori
outbreak
full
research
period
specimen
store
viral
transport
medium
quickli
deliv
laboratori
ice
divid
aliquot
store
process
specimen
test
common
respiratori
virus
includ
influenza
viru
type
b
ifva
ifvb
parainfluenza
viru
piv
type
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
four
human
coronavirus
hcov
adenoviru
adv
rhinoviru
hrv
human
bocaviru
hbov
use
realtim
pcr
assay
viral
nucleic
acid
extract
specimen
use
high
pure
viral
nucleic
acid
kit
accord
manufactur
instruct
roch
mannheim
germani
nucleic
acid
elut
elut
buffer
store
analysi
detect
respiratori
virus
includ
ifva
ifvb
piv
rsv
hmpv
adv
hrv
hbov
perform
volum
use
primescript
one
step
rtpcr
kit
huayin
biolog
compani
china
accord
protocol
abi
fast
sequenc
detect
system
reaction
condit
follow
revers
transcript
min
initi
denatur
min
cycl
follow
cycl
denatur
anneal
extens
final
cool
second
posit
neg
control
includ
run
nation
committe
clinic
laboratori
standard
guidelin
molecular
diagnosi
infecti
diseas
adopt
prevent
crosscontamin
statist
analysi
done
use
twotail
fisher
test
consid
signific
statist
analysi
perform
statist
analysi
system
softwar
total
sampl
collect
patient
ili
period
enrol
investig
male
femal
patient
age
rang
month
year
detect
limit
realtim
rtpcr
assay
copi
first
pcr
reaction
intraassay
coeffici
variabl
cv
interassay
cv
reaction
specif
realtim
rtpcr
assay
test
viral
cdna
target
virus
two
nontarget
virus
amplifi
product
observ
target
virus
product
obtain
nontarget
virus
data
shown
among
patient
test
found
posit
least
one
viru
neg
respiratori
virus
test
tabl
pathogen
investig
monthli
rate
respiratori
virus
rang
among
subject
among
posit
sampl
singl
infect
account
coinfect
account
expect
influenza
virus
hrv
frequent
identifi
high
incid
respect
among
subject
ili
sampl
examin
posit
influenza
virus
ifva
account
ifvb
account
influenza
case
subtyp
detect
case
pandem
influenza
viru
infect
identifi
sentinel
surveil
one
influenza
viru
detect
subtyp
onestep
rtpcr
virus
found
less
sampl
hmpv
rsv
adv
hbov
rare
detect
low
posit
rate
tabl
etiolog
distribut
ili
case
age
gender
shown
tabl
differ
posit
rate
observ
male
femal
pvalu
patient
age
rang
month
year
subject
children
year
accord
pathogen
test
respiratori
virus
occur
age
group
posit
rate
five
age
group
respect
tabl
signific
differ
posit
rate
among
age
group
pvalu
group
incid
singl
coinfect
respect
common
viral
pathogen
ifva
hrv
rsv
ifvb
common
virus
detect
schoolag
group
group
group
howev
detect
group
detect
age
group
rsv
detect
children
less
year
old
adult
older
year
old
figur
illustr
tempor
distribut
individu
viru
detect
overal
posit
rate
respiratori
virus
juli
juli
throughout
studi
period
ili
circul
virus
observ
throughout
year
pattern
influenza
occurr
vari
month
year
increas
viral
activ
observ
influenza
b
viru
detect
everi
month
everi
year
infect
predominantli
observ
januari
march
novemb
decemb
hrv
activ
examin
mani
month
year
rsv
infect
occur
predominantli
februari
march
octob
decemb
hmpv
observ
januari
march
septemb
decemb
monthli
distribut
respiratori
virus
rel
constant
clear
season
pattern
patient
present
fever
cough
inclus
criteria
frequent
symptom
sore
throat
rhinorrhea
headach
muscular
pain
pneumonia
tabl
signific
differ
patient
singl
infect
coinfect
fiftysix
coinfect
least
two
respiratori
virus
detect
rate
subject
posit
group
dual
infect
tripl
infect
quadrupl
infect
found
coinfect
patient
year
age
hrv
rsv
detect
respect
coinfect
tabl
shown
occurr
rate
singl
infect
significantli
higher
pvalu
group
age
year
group
age
year
signific
differ
pvalu
found
coinfect
group
age
year
group
age
year
influenzalik
ill
seriou
health
econom
burden
individu
cost
per
episod
ill
repres
approxim
monthli
percapita
incom
resid
becom
nation
public
health
detect
monitor
prioriti
nevertheless
data
epidemiolog
featur
etiolog
characterist
influenzalik
ill
moredevelop
region
world
less
known
etiolog
influenzalik
ill
china
especi
citi
accur
rapid
analysi
broad
rang
viral
agent
critic
etiolog
investig
present
studi
continu
surveil
respiratori
virus
patient
influenzalik
ill
conduct
huizhou
china
juli
juli
detect
rate
respiratori
virus
patient
ili
variabl
report
report
studi
overal
detect
rate
respiratori
virus
consist
previou
find
rang
littl
lower
observ
studi
perform
franc
differ
could
due
environment
factor
popul
distribut
econom
statu
diagnost
techniqu
use
addit
sampl
period
could
also
lead
differ
detect
rate
among
studi
hasman
et
al
carri
studi
two
success
winter
usa
found
sampl
patient
influenzalik
ill
posit
least
one
viru
studi
respiratori
specimen
collect
winter
contrast
studi
conduct
continu
juli
juli
includ
epidem
also
nonepidem
season
influenzalik
ill
furthermor
infect
yet
unknown
virus
may
respons
ili
bacteria
pneumonia
c
pneumonia
investig
studi
respiratori
virus
found
commonli
differ
consider
among
studi
usa
influenza
viru
infect
found
commonli
follow
rsv
piv
franc
respiratori
virus
detect
frequent
hmpv
rsv
itali
belgium
sequenc
influenza
viru
adv
piv
influenza
viru
hrv
rsv
respect
studi
virus
detect
frequent
influenza
virus
posit
rate
data
consist
posit
rate
observ
zhuhai
ifva
preval
ifvb
studi
versu
higher
incid
ifvb
ifva
observ
jinan
studi
also
highlight
clear
season
distribut
ifv
ifvb
activ
winter
ifva
activ
spring
summer
influenza
virus
detect
influenza
viru
activ
spring
summer
novel
avianorigin
influenza
viru
emerg
spread
among
human
china
spring
order
find
patient
without
delay
ili
surveil
nation
sentinel
hospit
mainland
china
strengthen
possibl
reason
peak
viru
detect
apriljuli
sampl
collect
etiolog
investig
studi
period
viru
promin
subtyp
huizhou
subtyp
detect
possibl
epidem
interf
appear
subtyp
total
case
ili
ifvb
predomin
viral
pathogen
occur
mainli
cold
winter
incid
influenza
b
significantli
higher
among
patient
ili
schoolag
group
group
hrv
second
frequent
viru
detect
found
subject
lower
posit
rate
older
age
group
find
agreement
previou
studi
suggest
hrv
respons
upper
acut
respiratori
tract
infect
children
adult
studi
hrv
seem
occur
throughout
year
discern
incid
peak
consist
previou
find
rsv
report
almost
common
influenza
virus
greatest
impact
children
year
studi
show
rsv
infect
occur
predominantli
februari
march
octob
decemb
major
case
children
five
year
old
may
attribut
develop
immun
state
vulner
infect
hmpv
recogn
major
pathogen
lower
respiratori
tract
infect
children
wherea
also
detect
adult
patient
report
hmpv
mostli
detect
june
juli
anoth
studi
observ
januarymarch
septemberdecemb
etiolog
signific
season
distribut
hmpv
infect
adult
requir
research
studi
suggest
human
coronavirus
posit
rate
approxim
rel
import
pathogen
ili
patient
found
children
less
year
old
common
infant
ili
first
identifi
shown
season
circul
coinfect
one
respiratori
viru
posit
rate
less
frequent
previous
report
dual
infect
significantli
frequent
tripl
infect
children
less
year
old
like
coinfect
age
group
studi
unfortun
clinic
signific
coinfect
studi
clear
due
lack
inform
patient
studi
suggest
coinfect
associ
moresever
symptom
singl
infect
research
requir
better
understand
clinic
signific
singl
versu
multipl
viral
coinfect
address
role
bacteri
co
infect
involv
sever
respiratori
ill
children
less
year
old
frequent
becam
outpati
respiratori
virus
detect
highest
posit
rate
similar
previou
studi
possibl
reason
immun
system
child
five
year
old
naiv
suscept
viral
infect
howev
unclear
whether
particular
age
group
higher
risk
get
coinfect
sampl
bias
toward
young
patient
main
limit
studi
focus
viral
etiolog
evalu
recent
identifi
virus
human
polyomaviru
herp
simplex
viru
atyp
etiolog
pneumonia
c
pneumonia
possibl
limit
might
prevent
possibl
address
key
question
bacteri
pathogen
possibl
role
viral
bacteri
coinfect
inclus
bacteri
pathogen
futur
studi
taken
consider
nevertheless
studi
first
systemat
investig
epidemiolog
etiolog
ili
provid
background
inform
concern
respiratori
viral
etiolog
huizhou
citi
guangdong
provinc
find
could
serv
refer
govern
offic
design
implement
effect
intervent
plan
also
provid
use
inform
clinician
treat
patient
present
ili
systemat
test
respiratori
virus
necessari
better
understand
diseas
burden
respiratori
pathogen
one
step
forward
toward
develop
therapeut
prevent
strategi
one
research
interest
futur
relationship
climat
occurr
ili
find
help
establish
effect
public
health
measur
interfer
time
identif
highrisk
individu
applic
vaccin
social
distanc
